1. Home
  2. ANVS vs KOSS Comparison

ANVS vs KOSS Comparison

Compare ANVS & KOSS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ANVS
  • KOSS
  • Stock Information
  • Founded
  • ANVS 2008
  • KOSS 1953
  • Country
  • ANVS United States
  • KOSS United States
  • Employees
  • ANVS N/A
  • KOSS N/A
  • Industry
  • ANVS Biotechnology: Pharmaceutical Preparations
  • KOSS Consumer Electronics/Appliances
  • Sector
  • ANVS Health Care
  • KOSS Consumer Staples
  • Exchange
  • ANVS Nasdaq
  • KOSS Nasdaq
  • Market Cap
  • ANVS 44.6M
  • KOSS 49.5M
  • IPO Year
  • ANVS 2020
  • KOSS N/A
  • Fundamental
  • Price
  • ANVS $2.67
  • KOSS $5.06
  • Analyst Decision
  • ANVS Strong Buy
  • KOSS
  • Analyst Count
  • ANVS 4
  • KOSS 0
  • Target Price
  • ANVS $18.00
  • KOSS N/A
  • AVG Volume (30 Days)
  • ANVS 433.2K
  • KOSS 68.7K
  • Earning Date
  • ANVS 08-14-2025
  • KOSS 08-28-2025
  • Dividend Yield
  • ANVS N/A
  • KOSS N/A
  • EPS Growth
  • ANVS N/A
  • KOSS N/A
  • EPS
  • ANVS N/A
  • KOSS N/A
  • Revenue
  • ANVS N/A
  • KOSS $12,433,361.00
  • Revenue This Year
  • ANVS N/A
  • KOSS N/A
  • Revenue Next Year
  • ANVS N/A
  • KOSS N/A
  • P/E Ratio
  • ANVS N/A
  • KOSS N/A
  • Revenue Growth
  • ANVS N/A
  • KOSS N/A
  • 52 Week Low
  • ANVS $1.11
  • KOSS $4.00
  • 52 Week High
  • ANVS $13.91
  • KOSS $11.84
  • Technical
  • Relative Strength Index (RSI)
  • ANVS 57.27
  • KOSS 49.75
  • Support Level
  • ANVS $2.63
  • KOSS $5.02
  • Resistance Level
  • ANVS $2.97
  • KOSS $5.63
  • Average True Range (ATR)
  • ANVS 0.25
  • KOSS 0.25
  • MACD
  • ANVS 0.03
  • KOSS 0.02
  • Stochastic Oscillator
  • ANVS 82.61
  • KOSS 50.00

About ANVS Annovis Bio Inc.

Annovis Bio Inc is a clinical-stage pharmaceutical company focused on developing and commercializing drugs for the treatment of Parkinson's and Alzheimer's diseases and other neurodegenerative diseases. The pipeline products of the company consists of: Buntanetap for chronic neurodegeneration - including AD and PD; ANVS405 for acute neurodegeneration; and ANVS301 for AD.

About KOSS Koss Corporation

Koss Corp is engaged in the design, manufacture, and sale of stereo headphones and related accessory products. It operates in the audio/video industry segment of the home entertainment industry. The company markets a line of headphones, wireless Bluetooth headphones, wireless Bluetooth speakers, computer headsets, telecommunications headsets, and active noise-canceling headphones. The majority of the firm's revenue is derived from sales of stereo headphones.

Share on Social Networks: